Nifedipine Bioavailability Study With Oral Single Doses Under Fasting and Fed Conditions

NCT00884442 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Bioavailability, Therapeutical Indication Not Studied

Interventions

DRUG: Nifedipine (Gen-nifedipine extended release, previously referred to as Gen-Nifedipine XL)
DRUG: Nifedipine (Bayer Healthcare AG manufactured as Adalat® XL®, Adalat® LA, Adalat® Crono, Adalat® OROS)

Sponsor

SocraTec R&D GmbH

Collaborators

[object Object]